Growing evidence indicated that ROS participated into the activation process of phosphatidylinositol 3‐kinase‐protein kinase B (PI3K)–Akt signalling and the mitogen‐activated protein (MAP) kinase signalling, thus contributing to aggressive cell proliferation, and migration in cancers.30 The gene discussed is AKT1; the disease is cancer.